What is TransMedics Group, Inc.'s revenue?

TransMedics Group, Inc. (TMDX) generated $635.9M in revenue over the trailing twelve months, up 30.2% year over year.

Is TransMedics Group, Inc. profitable?

TransMedics Group, Inc. reported $171.9M in net income over the trailing twelve months, a 27.0% net margin.

What are TransMedics Group, Inc.'s profit margins?

Gross margin is 59.1% and operating margin is 14.9%, with a 27.0% net margin.

What is TransMedics Group, Inc.'s earnings per share?

TransMedics Group, Inc.'s diluted EPS over the trailing twelve months is $4.37.

Where does TransMedics Group, Inc.'s income statement data come from?

Every line is extracted from TransMedics Group, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

TransMedics Group, Inc. TMDX Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Total revenue	$635.89M+5.0%	$605.49M+6.9%	$566.35M+6.6%	$531.29M+8.8%	$488.23M+10.6%
Total cost of revenue	$260.15M+7.2%	$242.69M+7.9%	$224.95M+5.3%	$213.62M+8.0%	$197.88M+10.3%
Gross profit	$375.74M+3.6%	$362.81M+6.3%	$341.41M+7.5%	$317.68M+9.4%	$290.35M+10.8%
Gross margin	59.1%-0.8pp	59.9%-0.4pp	60.3%+0.5pp	59.8%+0.3pp	59.5%+0.1pp
Research and development	$76.77M+11.2%	$69.06M+6.5%	$64.82M+1.6%	$63.82M+3.4%	$61.75M+10.3%
Selling, general and administrative	$204.53M+10.5%	$185.17M+2.5%	$180.63M+1.9%	$177.27M+0.7%	$176.08M+4.4%
Total operating expenses	$281.3M+10.7%	$254.22M+3.6%	$245.45M+1.8%	$241.1M+1.4%	$237.83M+5.9%
Operating income	$94.44M-13.0%	$108.58M+13.2%	$95.95M+25.3%	$76.58M+45.8%	$52.52M+40.1%
Operating margin	14.9%-3.1pp	17.9%+1.0pp	16.9%+2.5pp	14.4%+3.7pp	10.8%+2.3pp
Interest expense	$17.49M+26.9%	$13.78M-1.6%	$14M-0.9%	$14.13M-1.0%	$14.27M-1.0%
Other income (expense), net	——	——	-$3.08M-23.8%	-$2.49M-1.2%	-$2.46M-43.1%
Income before income taxes	$89.33M-16.9%	$107.52M+15.8%	$92.88M+25.4%	$74.09M+48.0%	$50.06M+39.9%
Income tax expense	-$82.59M+0.2%	-$82.77M-7,537%	$1.11M-54.2%	$2.43M+118%	$1.11M+253%
Net income	$171.92M-9.7%	$190.29M+107%	$91.77M+28.1%	$71.66M+46.4%	$48.95M+38.0%
Net margin	27%-4.4pp	31.4%+15.2pp	16.2%+2.7pp	13.5%+3.5pp	10%+2.0pp
Diluted earnings per share	$4.37-10.3%	$4.87+96.4%	$2.48+27.8%	$1.94+41.6%	$1.37+34.3%
EBITDA	$127.35M-6.2%	$135.77M+11.9%	$121.35M+21.0%	$100.3M+35.3%	$74.11M+29.4%
EBITDA margin	20%-2.4pp	22.4%+1.0pp	21.4%+2.5pp	18.9%+3.7pp	15.2%+2.2pp
EBIT	$94.44M-13.0%	$108.58M+13.2%	$95.95M+25.3%	$76.58M+45.8%	$52.52M+40.1%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about TransMedics Group, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is TransMedics Group, Inc.'s revenue?: TransMedics Group, Inc. (TMDX) generated $635.9M in revenue over the trailing twelve months, up 30.2% year over year.
Is TransMedics Group, Inc. profitable?: TransMedics Group, Inc. reported $171.9M in net income over the trailing twelve months, a 27.0% net margin.
What are TransMedics Group, Inc.'s profit margins?: Gross margin is 59.1% and operating margin is 14.9%, with a 27.0% net margin.
What is TransMedics Group, Inc.'s earnings per share?: TransMedics Group, Inc.'s diluted EPS over the trailing twelve months is $4.37.
Where does TransMedics Group, Inc.'s income statement data come from?: Every line is extracted from TransMedics Group, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.